Opioid Induced Side Effects Treatment Market

Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.
Opioid Induced Side Effects Treatment Market contains market size and forecasts of Opioid Induced Side Effects Treatment in Global, including the following market information:
Global Opioid Induced Side Effects Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Opioid Induced Side Effects Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Risperidone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Induced Side Effects Treatment include Shionogi, Cubist Pharmaceuticals, SLA Pharma, AstraZeneca, AIKO Biotechnology and Progenics Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Induced Side Effects Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Induced Side Effects Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Opioid Induced Side Effects Treatment Market Segment Percentages, by Type, 2021 (%)
Risperidone
Methylphenidate
Cetirizine
Other
Global Opioid Induced Side Effects Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Opioid Induced Side Effects Treatment Market Segment Percentages, by Application, 2021 (%)
Drug Overdose Treatment
Pain Treatment
Other
Global Opioid Induced Side Effects Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Opioid Induced Side Effects Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Side Effects Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Opioid Induced Side Effects Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shionogi
Cubist Pharmaceuticals
SLA Pharma
AstraZeneca
AIKO Biotechnology
Progenics Pharmaceuticals